Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma A/S - American Depositary Shares (NQ: ASND )

164.15 +3.70 (+2.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 560,205
Open 160.35
Bid (Size) 65.58 (2)
Ask (Size) 170.48 (1)
Prev. Close 160.45
Today's Range 157.66 - 167.29
52wk Range 111.09 - 169.37
Shares Outstanding 57,152,295
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
Does ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) show the characteristics of a Minervini super stock?
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND). 
Via Chartmill

Performance

YTD
+18.95%
+18.95%
1 Month
+3.71%
+3.71%
3 Month
+28.04%
+28.04%
6 Month
+25.96%
+25.96%
1 Year
+19.88%
+19.88%

More News

Read More
Looking Into Ascendis Pharma's Recent Short Interest
Via Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
Via Benzinga
Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) a Minervini-style stock?
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
Via Benzinga
Earnings Scheduled For February 12, 2025
Via Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
Via Benzinga
Why Is BioMarin Stock Trading Higher On Thursday?
Via Benzinga
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
Via Benzinga
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
Via Stocktwits
Looking Into Ascendis Pharma's Recent Short Interest
Via Benzinga
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Peering Into Ascendis Pharma's Recent Short Interest
Via Benzinga
(ASND) - Analyzing Ascendis Pharma's Short Interest
Via Benzinga
A Glimpse of Ascendis Pharma's Earnings Potential
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $5,600 Today
Via Benzinga
Can BioMarin Stock Live Up to Wall Street’s High Expectations?
Via MarketBeat
Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
Via Benzinga
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
Via Benzinga
BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth
Via Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
3 Oversold Stocks with Big RSI Rebound Potential
Via MarketBeat
Topics Economy
Exposures Interest Rates
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.